Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic Dysfunction Associated Steatohepatitis (MASH)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06121999
What this trial is testing

Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults

Who this might be right for
Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD)Metabolic Associated-dysfunction Steatohepatitis (MASH)
Grand Valley State University 24
Testing effectiveness (Phase 2)Looking for participantsNCT07427680
What this trial is testing

Study of TGM-312-SC01 in Healthy Participants and Adults With MASH

Who this might be right for
Healthy ParticipantsMASH - Metabolic Dysfunction-Associated Steatohepatitis
Tangram Therapeutics Plc 99
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631637
What this trial is testing

Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Regeneron Pharmaceuticals 150
Large-scale testing (Phase 3)Looking for participantsNCT06318169
What this trial is testing

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc. 1,350
Not applicableNot Yet RecruitingNCT07760909
What this trial is testing

Metabolic Flux Analysis in Metabolic Dysfunction-Associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Dysfunction-Associated SteatohepatitisObesity+1 more
Vanderbilt University Medical Center 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07016633
What this trial is testing

To Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of IMM-H014 in Patients With MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Changchun Intellicrown Pharmaceutical Co. LTD 40
Early research (Phase 1)Looking for participantsNCT06704516
What this trial is testing

COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study

Who this might be right for
MenopauseMetabolic Dysfunction Associated Steatotic Liver Disease
University of Oxford 10
Not applicableLooking for participantsNCT06824974
What this trial is testing

Time-restricted Eating and Healthy Eating in Patients With Metabolic Liver Disease or Cancer

Who this might be right for
Liver Cancer, AdultMASH - Metabolic Dysfunction-Associated SteatohepatitisObesity and Overweight
University of California, San Diego 50
Testing effectiveness (Phase 2)Study completedNCT06675929
What this trial is testing

Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH

Who this might be right for
Compensated Liver CirrhosisMetabolic Dysfunction Associated Steatohepatitis (MASH)
Boehringer Ingelheim 28
Early research (Phase 1)Study completedNCT07801313
What this trial is testing

Phase 1 Clinical Study of MWN105 Injection in Healthy Chinese Volunteers

Who this might be right for
Overweight , ObesityType 2 Diabetes Mellitus (T2DM)MASH - Metabolic Dysfunction-Associated Steatohepatitis
Shanghai Minwei Biotechnology Co., Ltd 55
Not applicableNot Yet RecruitingNCT06795646
What this trial is testing

Clinical Classification of MAFLD Based Liver Biopsy

Who this might be right for
Metabolic Dysfunction Associated Steatotic Liver DiseaseMetabolic Dysfunction-associated Steatohepatitis (MASH)
Beijing Friendship Hospital 2,000
Large-scale testing (Phase 3)WithdrawnNCT06594523
What this trial is testing

Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis

Who this might be right for
MASHNASHMetabolic Dysfunction-associated Steatohepatitis+3 more
Sagimet Biosciences Inc.
Not applicableLooking for participantsNCT07321925
What this trial is testing

Thermoacoustic Method for Estimating Liver Fat Fraction

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Fatty Liver Disease, Nonalcoholic
Endra Lifesciences 49
Early research (Phase 1)Study completedNCT07331545
What this trial is testing

Safety, Tolerability, PK, PD, and Immunogenicity of QL2401 in Healthy Chinese Adults

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis(MASH)
Qilu Pharmaceutical Co., Ltd. 71
Testing effectiveness (Phase 2)Looking for participantsNCT07288138
What this trial is testing

A Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis
Eccogene 160
Large-scale testing (Phase 3)Looking for participantsNCT06215716
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

Who this might be right for
NASH With FibrosisMASH With Fibrosis
Akero Therapeutics, Inc 1,650
Large-scale testing (Phase 3)Looking for participantsNCT06419374
What this trial is testing

Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
89bio, Inc. 762
Not applicableLooking for participantsNCT07313007
What this trial is testing

Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis (MASH)
Hospices Civils de Lyon 24
Testing effectiveness (Phase 2)Study completedNCT03938246
What this trial is testing

Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Sagimet Biosciences Inc. 142
Testing effectiveness (Phase 2)Active Not RecruitingNCT06108219
What this trial is testing

A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-associated Steatohepatitis (MASH)
Corcept Therapeutics 175
Next Page